These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20002936)

  • 1. Another key molecule for pathogenesis of hepatocellular carcinoma.
    Tada M; Omata M
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1803-4. PubMed ID: 20002936
    [No Abstract]   [Full Text] [Related]  

  • 2. Secreted protein acidic and rich in cysteine (SPARC) gene polymorphism association with hepatocellular carcinoma in Italian patients.
    Segat L; Milanese M; Pirulli D; Trevisiol C; Lupo F; Salizzoni M; Amoroso A; Crovella S
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1840-6. PubMed ID: 19817957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship of single nucleotide polymorphism, environmental factors and the hereditary susceptibility of hepatocellular carcinoma].
    Ji L; Yu H
    Wei Sheng Yan Jiu; 2009 Mar; 38(2):233-7. PubMed ID: 19408671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
    Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
    Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular tools and hepatocellular carcinoma: Adding help or confusion in liver transplantation?
    Vibert E; Samuel D
    J Hepatol; 2008 Oct; 49(4):498-501. PubMed ID: 18678433
    [No Abstract]   [Full Text] [Related]  

  • 6. [Genetic polymorphism of UDP-glucuronosyltransferase 1F and susceptibility to hepatocellular carcinoma].
    Liu C; Bian J; Jiang F; Shen F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):324-8. PubMed ID: 12170472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between single-nucleotide polymorphism and susceptibility to hepatocellular carcinoma].
    Gu X; Gao CF
    Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):235-7. PubMed ID: 20380807
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
    Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
    J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association analysis between the Cdc6 G1321A polymorphism and the risk for non-Hodgkin lymphoma and hepatocellular carcinoma.
    Xiong XD; Qiu FE; Fang JH; Shen Y; Liang C; Jiang W; Zhuang SM
    Mutat Res; 2009 Mar; 662(1-2):10-5. PubMed ID: 19101572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma: susceptibility markers.
    Blum HE
    IARC Sci Publ; 2001; 154():241-4. PubMed ID: 11220663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC).
    Chen GG; Ho RL; Wong J; Lee KF; Lai PB
    Eur J Surg Oncol; 2007 Sep; 33(7):882-6. PubMed ID: 17433605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association exists between E-cadherin gene polymorphism and tumor recurrence in patients with hepatocellular carcinoma after transplantation.
    Li XD; Wu LM; Xie HY; Xu X; Zhou L; Liang TB; Wang WL; Shen Y; Zhang M; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):254-8. PubMed ID: 17548247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinoma.
    Wang XQ; Luk JM; Garcia-Barcelo M; Miao X; Leung PP; Ho DW; Cheung ST; Lam BY; Cheung CK; Wong AS; Lau SS; So MT; Yu WC; Cai Q; Liu KS; Hui CK; Lau GK; Poon RT; Wong J; Fan ST
    Clin Cancer Res; 2006 Sep; 12(17):5248-52. PubMed ID: 16951245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNFR1 promoter -329G/T polymorphism results in allele-specific repression of TNFR1 expression.
    Kim S; Moon SM; Kim YS; Kim JJ; Ryu HJ; Kim YJ; Choi JW; Park HS; Kim DG; Shin HD; Rutherford MS; Oh B; Lee JK
    Biochem Biophys Res Commun; 2008 Apr; 368(2):395-401. PubMed ID: 18243134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection].
    Kim YJ; Lee HS
    Korean J Hepatol; 2009 Mar; 15(1):7-14. PubMed ID: 19346781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation.
    Wu LM; Zhang F; Xie HY; Xu X; Chen QX; Yin SY; Liu XC; Zhou L; Xu XB; Sun YL; Zheng SS
    Clin Genet; 2008 Mar; 73(3):273-8. PubMed ID: 18177474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling of liver tumors: classification and clinical translation for decision making.
    Pinyol R; Nault JC; Quetglas IM; Zucman-Rossi J; Llovet JM
    Semin Liver Dis; 2014 Nov; 34(4):363-75. PubMed ID: 25369299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene.
    Ho SY; Wang YJ; Chen HL; Chen CH; Chang CJ; Wang PJ; Chen HH; Guo HR
    Cancer Causes Control; 2004 Sep; 15(7):657-63. PubMed ID: 15280623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
    Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
    Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.